menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Amneal Gets FDA Nod For Memantine/Donepezil & Everolimus

    BUSINESSWIRE

    Xiamen LP Pharm’s Generic Memantine:Donepezil HCl Receives Tentative Approval In U.S

    FDA

    Health Canada Issues Recall of Donepezil 10 mg Tablet

    HEALTH CANADA

    Corium Announces Publication of Favorable ADLARITY Skin Irritation Trial Data

    PR NEWSWIRE

    Corium, Lotus Pharmaceutical Partner on Alzheimer`s Drug Adlarity

    CONTRACT PHARMA

    Xiamen`s Generic Memantine, Donepezil Receives Approval in the U.S.

    FDA

    Corium Announces Publication of ADLARITY Clinical Trial Data

    PRNEWSWIRE

    KemPharm Earns $1.975 M Fee from Corium Following FDA Approval of ADLARITY

    GLOBENEWSWIRE

    FDA Approves Corium`s ADLARITY in Alzheimer`s Disease

    PRNEWSWIRE

    Icure Acquires Drug Product Approval for World’s First Donepezil Patch in Korea

    BUSINESSWIRE

    Enforcement Report - Week of September 8, 2021

    FDA

    Granules India, Jubilant Cadista recall products in US market

    BUSINESS-STANDARD

    People often skip neurological meds when out-of-pocket costs rise

    REUTERS

    Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications

    FEDERALREGISTER

    Celltrion to start phase 3 clinical trials for patch-type donepezil

    THE INVESTOR

    What does the past generation of failure in Alzheimer’s R&D look like

    ENDPTS

    Hisun Pharm Hangzhou`s Generic Donepezil Hydrochloride Receives Approval In US

    FDA

    Local drug makers strive to conquer neurological diseases

    KOREA BIOMED

    Eisai accelerates dementia drug discovery research

    PHARMAPHORUM

    Eisai partners with Chong Kun Dang for drug sales

    BIOSPECTRUM ASIA

    Corium close to partnering on transdermal Alzheimer’s drug

    IN PHARMATECHNOLOGIST

    Axovant Much-Hyped Alzheimer`s Drug Flunks Phase III Test

    BIOSPACE

    Cadila Pharms Ltd Generic Donepezil Hydrochloride Receives Approval In Us

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Namzaric (Memantine Hydrochloride Extended-release and Donepezil Hydrochloride )

    FDA

    Enforcement Report - Week of May 3, 2017

    FDA

    Neurotrope announces +ve top-line results from phase 2 study of Bryostatin-1

    PHARMABIZ

    Zhejiang Hisun Pharm’s Generic Donepezil Hydrochloride Receives Approval In US

    FDA

    Amneal`s Generic Donepezil HCL; Memantine HCL Receives Approval In US

    FDA

    Eisai`s Lenvima moves toward Nexavar showdown with phase 3 liver cancer win

    FIERCE PHARMA

    Eisai, Keio University enter joint research pact to discover & develop new drugs

    PHARMABIZ

    Allergan chases high-dose, low side effects Alzheimer’s combo in biotech buy

    FIERCE BIOTECH

    Allergan broadens Alzheimer`s campaign after expanding Namzaric indication

    FIERCE PHARMA

    Unichem`s Generic Donepezil HCL Receives Approval In US

    FDA

    Allergan & Adamas Announce U.S Availability of New Dosage Strengths for NAMZARIC

    PR NEWSWIRE

    Allergan and Adamas Announce New Expanded Indication for NAMZARIC

    PR NEWSWIRE

    Unichem Labs` Generic Donepezil Approved in US For cognition in Alzheimer`s

    FDA

    Eisai gains Philippines approval for Aricept in new license

    FIERCE PHARMA

    Indicus’ Generic Aricept Approval Reveals Potential for U.S. Government Sales

    TWOFOUR INSIGHT

    Indicus Pharma`s Generic Donepezil HCl approved in US to treat dementia

    FDA

    Lupin launches generic Aricept tablets in US market

    ECONOMIC TIMES

    Chase Pharma raises $12M for Alzheimer`s R&D

    FIERCE BIOTECH

    Pharma`s DTC ad spending soars past $5B in 2015

    FIERCE PHARMA MARKETING

    ANI Pharma and Dexcel Announce FDA Approval of Donepezil HCl 23mg Tablets

    PR NEWSWIRE

    Dexcel Pharma`s Generic Donepezil Hydrochloride approved in US to treat mild to moderate dementia

    FDA

    Dementia prescriptions six times higher than a decade ago

    PHARMATIMES

    Singapore`s TauRx mulls Nasdaq IPO & sees future for Alzheimer`s treatment

    FIERCE PHARMA ASIA

    Adamas soars as its Parkinson`s drug comes through in Phase III

    FIERCE BIOTECH

    Health Canada warns potential,allergic reactions to OTC topical products

    FDA

    Struggling Eisai looks for help in China with new generics deal

    FIERCE PHARMA

    Allergan counting on January formulary boost to jump-start Namzaric launch

    FIERCE PHARMA MARKETING

    Allergan, shut down on Namenda hard switch, takes it up with SCOTUS

    FIERCE PHARMA

    Lupin`s Generic Donepezil HCL approved in US for Alzheimer

    FDA

    Mylan`s Generic Donepezil HCl approved in US for Alzheimer`s Disease

    FDA

    Novartis, Allergan Alzheimer`s meds linked to abnormal behavior

    FIERCE PHARMA

    Roche CEO: Big Data needs Big Pharma, and vice versa

    FIERCE PHARMA

    Allergan`s H2 looks lighter without generics, but 10% growth on tap for 2016

    FIERCE PHARMA

    Takeda crosses Actos settlement threshold as 96% of plaintiffs seek resolution

    FIERCE PHARMA ASIA

    Sun`s Generic Donepezil Hcl (23Mg) Approved in US For Dementia

    FDA

    UPDATED: Eisai to Shed 200-plus Jobs as it Pares Down U.S. Workforce

    FIERCE PHARMA

    AdverseEvents: Analysis of side-effect reports turns up troubling safety signals for Novartis, Eisai drugs

    FIERCE PHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.